The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
New adjuvants for human vaccines
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Taking dendritic cells into medicine
Steinman, R. M., & Banchereau, J. (2007) · Nature · doi:10.1038/nature06175 · Cited by 2,127
Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
Eisenbarth, S. C., Colegio, O. R., O’Connor, W., Sutterwala, F. S., & Flavell, R. A. (2008) · Nature · doi:10.1038/nature06939 · Cited by 1,542
Therapeutic potential of Toll-like receptor 9 activation
Krieg, A. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2059 · Cited by 1,246
LeibundGut-Landmann, S., Groß, O., Robinson, M. J., Osorio, F., Slack, E. C., Tsoni, S. V., Schweighoffer, E., Tybulewicz, V., Brown, G. D., Ruland, J., et al. (2007) · Nature Immunology · doi:10.1038/ni1460 · Cited by 1,191
Napolitani, G., Rinaldi, A., Bertoni, F., Sallusto, F., & Lanzavecchia, A. (2005) · Nature Immunology · doi:10.1038/ni1223 · Cited by 1,157
Towards an understanding of the adjuvant action of aluminium
Marrack, P., McKee, A. S., & Munks, M. W. (2009) · Nature Reviews Immunology · doi:10.1038/nri2510 · Cited by 887
Didierlaurent, A. M., Morel, S., Lockman, L., Giannini, S. L., Bisteau, M., Carlsen, H., Kielland, A., Vosters, O., Vanderheyde, N., Schiavetti, F., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901474 · Cited by 758
Alonso, P. L., Sacarlal, J., Aponte, J. J., Leach, A., Macete, E., Milman, J., Mandomando, I., Spiessens, B., Guinovart, C., Espasa, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17223-1 · Cited by 752
Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA
Saito, T., Owen, D. M., Jiang, F., Marcotrigiano, J., & Gale, M. (2008) · Nature · doi:10.1038/nature07106 · Cited by 744
Cutting Edge: Inflammasome Activation by Alum and Alum’s Adjuvant Effect Are Mediated by NLRP3
Li, H., Willingham, S. B., Ting, J. P.-Y., & Re, F. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.17 · Cited by 675
Kool, M., Pétrilli, V., De Smedt, T., Rolaz, A., Hammad, H., van Nimwegen, M., Bergen, I. M., Castillo, R., Lambrecht, B. N., & Tschopp, J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.3755 · Cited by 611
Querec, T., Bennouna, S., Alkan, S., Laouar, Y., Gorden, K., Flavell, R., Akira, S., Ahmed, R., & Pulendran, B. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051720 · Cited by 552
GIANNINI, S., HANON, E., MORIS, P., VANMECHELEN, M., MOREL, S., DESSY, F., FOURNEAU, M., COLAU, B., SUZICH, J., & LOSONKSY, G. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.06.005 · Cited by 496
Molecular and cellular signatures of human vaccine adjuvants
Mosca, F., Tritto, E., Muzzi, A., Monaci, E., Bagnoli, F., Iavarone, C., O'Hagan, D., Rappuoli, R., & De Gregorio, E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804699105 · Cited by 492
Self-citationFranchi, L., & Núñez, G. (2008) · European Journal of Immunology · doi:10.1002/eji.200838549 · Cited by 450
Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine
Clark, T. W., Pareek, M., Hoschler, K., Dillon, H., Nicholson, K. G., Groth, N., & Stephenson, I. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0907650 · Cited by 445
Seubert, A., Monaci, E., Pizza, M., O’Hagan, D. T., & Wack, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5402 · Cited by 430
Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age
Bejon, P., Lusingu, J., Olotu, A., Leach, A., Lievens, M., Vekemans, J., Mshamu, S., Lang, T., Gould, J., Dubois, M.-C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807381 · Cited by 417
Einstein, M. H., Baron, M., Levin, M. J., Chatterjee, A., Edwards, R. P., Zepp, F., Carletti, I., Dessy, F. J., Trofa, A. F., Schuind, A., et al. (2009) · Human Vaccines · doi:10.4161/hv.5.10.9518 · Cited by 402
McKee, A. S., Munks, M. W., MacLeod, M. K. L., Fleenor, C. J., Van Rooijen, N., Kappler, J. W., & Marrack, P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900164 · Cited by 392
Huleatt, J. W., Nakaar, V., Desai, P., Huang, Y., Hewitt, D., Jacobs, A., Tang, J., McDonald, W., Song, L., Evans, R. K., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2007.10.062 · Cited by 382
Mechanism of action of clinically approved adjuvants
Lambrecht, B. N., Kool, M., Willart, M. A., & Hammad, H. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.01.004 · Cited by 354
The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine
Podda, A. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00499-0 · Cited by 333
Wille-Reece, U., Flynn, B. J., Loré, K., Koup, R. A., Kedl, R. M., Mattapallil, J. J., Weiss, W. R., Roederer, M., & Seder, R. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507484102 · Cited by 332
Huleatt, J. W., Jacobs, A. R., Tang, J., Desai, P., Kopp, E. B., Huang, Y., Song, L., Nakaar, V., & Powell, T. J. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.08.013 · Cited by 299
Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro
Morefield, G. L., Sokolovska, A., Jiang, D., HogenEsch, H., Robinson, J. P., & Hem, S. L. (2005) · Vaccine · doi:10.1016/j.vaccine.2004.07.050 · Cited by 293
The path to a successful vaccine adjuvant – ‘The long and winding road’
O’Hagan, D. T., & De Gregorio, E. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.02.009 · Cited by 274
Self-citationGalli, G., Hancock, K., Hoschler, K., DeVos, J., Praus, M., Bardelli, M., Malzone, C., Castellino, F., Gentile, C., McNally, T., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903181106 · Cited by 263
Galli, G., Medini, D., Borgogni, E., Zedda, L., Bardelli, M., Malzone, C., Nuti, S., Tavarini, S., Sammicheli, C., Hilbert, A. K., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813390106 · Cited by 261
Self-citationAlum adjuvanticity: Unraveling a century old mystery
De Gregorio, E., Tritto, E., & Rappuoli, R. (2008) · European Journal of Immunology · doi:10.1002/eji.200838648 · Cited by 232
Self-citationBanzhoff, A., Gasparini, R., Laghi-Pasini, F., Staniscia, T., Durando, P., Montomoli, E., Capecchi, P., di Giovanni, P., Sticchi, L., Gentile, C., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004384 · Cited by 194
Dendritic Cells Internalize Vaccine Adjuvant after Intramuscular Injection
Dupuis, M., Murphy, T. J., Higgins, D., Ugozzoli, M., van Nest, G., Ott, G., & McDonald, D. M. (1998) · Cellular Immunology · doi:10.1006/cimm.1998.1283 · Cited by 185
Wille-Reece, U., Wu, C.-Y., Flynn, B. J., Kedl, R. M., & Seder, R. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7676 · Cited by 185
Zhu, Q., Egelston, C., Vivekanandhan, A., Uematsu, S., Akira, S., Klinman, D. M., Belyakov, I. M., & Berzofsky, J. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805325105 · Cited by 183
Aagaard, C., Hoang, T. T. K. T., Izzo, A., Billeskov, R., Troudt, J., Arnett, K., Keyser, A., Elvang, T., Andersen, P., & Dietrich, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005930 · Cited by 166
Levy, O., Suter, E. E., Miller, R. L., & Wessels, M. R. (2006) · Blood · doi:10.1182/blood-2005-12-4821 · Cited by 161
Rinaudo, C. D., Telford, J. L., Rappuoli, R., & Seib, K. L. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38330 · Cited by 160
Self-citationAtanackovic, D., Altorki, N. K., Cao, Y., Ritter, E., Ferrara, C. A., Ritter, G., Hoffman, E. W., Bokemeyer, C., Old, L. J., & Gnjatic, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707140104 · Cited by 158
IC31, a novel adjuvant signaling via TLR9, induces potent cellular and humoral immune responses
Schellack, C., Prinz, K., Egyed, A., Fritz, J. H., Wittmann, B., Ginzler, M., Swatosch, G., Zauner, W., Kast, C., Akira, S., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.03.071 · Cited by 158
Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system
Thoelen, S., Damme, P. V., Matheï, C., Leroux-Roels, G. G., Desombere, I., Safary, A., Vandepapelière, P., Slaoui, M., & Meheus, A. (1998) · Vaccine · doi:10.1016/s0264-410x(97)00254-5 · Cited by 156
Currently approved prophylactic HPV vaccines
Harper, D. M. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.123 · Cited by 150
Goto, N., Kato, H., Maeyama, J., Shibano, M., Saito, T., Yamaguchi, J., & Yoshihara, S. (1997) · Vaccine · doi:10.1016/s0264-410x(97)00054-6 · Cited by 136
Protective immunity to tuberculosis with Ag85B-ESAT-6 in a synthetic cationic adjuvant system IC31
Agger, E. M., Rosenkrands, I., Olsen, A. W., Hatch, G. J., Williams, A., Kritsch, C. E., Lingnau, K., von Gabain, A., Andersen, C. S., Korsholm, K. S., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.03.072 · Cited by 128
Lell, B., Agnandji, S. T., von Glasenapp, I., Haertle, S., Oyakhiromen, S., Issifou, S., Vekemans, J., Leach, A. J., Lievens, M., Dubois, M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007611 · Cited by 95
Review of hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine safety and efficacy
Barry, M. A., & Cooper, C. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.11.1731 · Cited by 93
Histopathological Studies of Reactions in Mice Injected with Aluminum‐Adsorbed Tetanus Toxoid
Goto, N., & Akama, K. (1982) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1982.tb00261.x · Cited by 91
Krumbiegel, D., Zepp, F., & Meyer, C. U. (2007) · Human Immunology · doi:10.1016/j.humimm.2007.08.001 · Cited by 74
Leroux-Roels, G. G. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903066695 · Cited by 70
Innate immune control of nucleic acid-based vaccine immunogenicity
Koyama, S., Coban, C., Aoshi, T., Horii, T., Akira, S., & Ishii, K. J. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.57 · Cited by 37
Shahzad, A., & Köhler, G. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.06.106 · Cited by 9
Cited by
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns
Bachmann, M. F., & Jennings, G. T. (2010) · Nature Reviews Immunology · doi:10.1038/nri2868 · Cited by 2,106
Vaccine Adjuvants: Putting Innate Immunity to Work
Coffman, R. L., Sher, A., & Seder, R. A. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.002 · Cited by 1,924
Immunological mechanisms of vaccination
Pulendran, B., & Ahmed, R. (2011) · Nature Immunology · doi:10.1038/ni.2039 · Cited by 1,089
Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
Kanekiyo, M., Wei, C.-J., Yassine, H. M., McTamney, P. M., Boyington, J. C., Whittle, J. R. R., Rao, S. S., Kong, W.-P., Wang, L., & Nabel, G. J. (2013) · Nature · doi:10.1038/nature12202 · Cited by 885
Synthetic Nanoparticles for Vaccines and Immunotherapy
Irvine, D. J., Hanson, M. C., Rakhra, K., & Tokatlian, T. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00109 · Cited by 763
Metadata
- Authors
- Mbow, M. L., De Gregorio, E., Valiante, N. M., & Rappuoli, R.
- Venue
- Current Opinion in Immunology
- Publisher
- Elsevier BV
- Published
- 2010-06
- Volume
- 22
- Issue
- 3
- Pages
- 411-416
- ISSN
- 0952-7915 (ISSN-L)
- OpenAlex
- W1980785560
- Cited by
- 406
- References
- 50
- FWCI
- 2.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.